Results 311 to 320 of about 1,994,828 (407)

Recommendations for bone‐directed therapy in patients with neuroendocrine tumour skeletal metastases at the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting

open access: yesInternal Medicine Journal, EarlyView.
Abstract The role of anti‐resorptive agents in patients with bone metastases from neuroendocrine neoplasms is unclear. Our aim was to review bone‐specific treatment recommendations by the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting (MDM).
Gayle Radley   +3 more
wiley   +1 more source

Multi-center multi-omics integration predicts individualized prognosis in medullary thyroid carcinoma. [PDF]

open access: yesNat Commun
Zhou Y   +25 more
europepmc   +1 more source

Modern Diets, Metabolic Inequity, and Race–Ethnic Disparities: Unraveling the Associations With MASLD and Cancer Risk

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is quickly emerging as a global public health concern, primarily fueled by the rising consumption of processed and ultraprocessed foods. This global health issue, showing a 50% increase in prevalence over two decades to 38% of the global population, is now the second most common ...
Arunkumar Krishnan   +9 more
wiley   +1 more source

The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid Carcinoma. [PDF]

open access: yesEndocr Relat Cancer
Kraft IL   +13 more
europepmc   +1 more source

Diagnostic Performance of the PrevoCheck for the Detection of Human Papillomavirus 16‐Driven Head and Neck Squamous Cell Carcinoma

open access: yesJournal of Oral Pathology &Medicine, EarlyView.
ABSTRACT Background Human papillomavirus (HPV)‐16 is the most commonly found HPV‐type in HPV‐induced oropharyngeal squamous cell carcinomas (OPSCC). The serological response to HPV oncoproteins could be a way to detect HPV‐driven OPSCC early. A rapid test for the detection of HPV16 L1 antibodies in blood was developed in 2015 (PrevoCheck).
Charlotte S. Schouten   +4 more
wiley   +1 more source

Molecular Alterations in Osteosarcomas of the Oral and Maxillofacial Region: A Scoping Review

open access: yesJournal of Oral Pathology &Medicine, EarlyView.
ABSTRACT Background Given the rarity and aggressive nature of osteosarcomas (OS) in the oral and maxillofacial region, understanding their molecular alterations is essential to improve diagnosis, prognosis, and guide targeted therapies. This study aimed to map molecular alterations associated with oral and maxillofacial OS, providing an overview of the
Iara Vieira Ferreira   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy